KDIGO Urine‑Output Criteria for Staging Acute Kidney Injury
Definition and Staging
- The KDIGO guideline defines Stage 1 AKI as urine output < 0.5 mL/kg/h for 6–12 hours. 1
- Stage 2 AKI is defined as urine output < 0.5 mL/kg/h for ≥ 12 hours. 1
- Stage 3 AKI is defined as urine output < 0.3 mL/kg/h for ≥ 24 hours or anuria for ≥ 12 hours. 1
- A total urine output of 300 mL over 24 hours meets the Stage 3 criterion in most adults because it corresponds to < 0.3 mL/kg/h for a typical body weight. [1][2]3
Example calculations (illustrative adult weights):
Body weight Hourly output (mL/h) Output per kg (mL/kg/h) 70 kg 12.5 0.18 60 kg 12.5 0.21 80 kg 12.5 0.16 For adults weighing > 40 kg, a urine volume of 300 mL/24 h will invariably satisfy the Stage 3 urine‑output definition. [1][2]
Clinical Implications
- Stage 3 AKI carries the highest in‑hospital mortality; patients who require renal replacement therapy have approximately a four‑fold increase in mortality compared with those in lower stages. 4
- Mortality risk rises incrementally with each advancing KDIGO stage. 4
Special Populations and Caveats
- Cirrhotic patients with ascites often have low urine output despite relatively preserved glomerular filtration; therefore, urine‑output criteria are unreliable and serum‑creatinine changes should be used for AKI diagnosis. [5][6]
- Patients receiving diuretics have confounded urine‑output measurements, making the criteria less dependable. [5][6]
Diagnostic Considerations
- AKI staging uses the most severe criterion met, whether it is based on serum creatinine or urine output. 1
- A patient who meets Stage 3 by urine output (<0.3 mL/kg/h for ≥ 24 h) and Stage 1 by serum creatinine (1.5–1.9 × baseline) is classified as Stage 3 AKI, because the urine‑output criterion is more severe. [3][4]1
Immediate Management of Stage 3 AKI Identified by Severe Oliguria
- Stop all nephrotoxic drugs (e.g., NSAIDs, ACE inhibitors, ARBs, aminoglycosides). 4
- Assess volume status and administer fluid resuscitation if the patient is hypovolemic. 4
- Rule out urinary tract obstruction with a renal ultrasound. 4
- Monitor serum creatinine and electrolytes every 4–6 hours. 4
- Obtain urgent nephrology consultation for any patient with Stage 2 or Stage 3 AKI. 7
- Evaluate for renal replacement therapy when severe oliguria is unresponsive to fluids, or when there is severe metabolic acidosis or uremic complications. 4
KDIGO Acute Kidney Injury: Definition, Staging, and Follow‑Up
Definition of AKI
- AKI is diagnosed when serum creatinine rises to ≥1.5 × baseline (or is presumed to have occurred) within a 7‑day window. 8
Staging Criteria
Stage 1
- Serum creatinine: increase to 1.5–1.9 × baseline or an absolute rise of ≥0.3 mg/dL (≈26.5 µmol/L).
- Urine output: <0.5 mL/kg/h sustained for 6–12 hours. 9, 8
Stage 2
Stage 3
- Serum creatinine: increase to ≥3.0 × baseline or rise to ≥4.0 mg/dL (≈353.6 µmol/L) or initiation of renal replacement therapy.
- Pediatric consideration (<18 years): estimated GFR falls <35 mL/min/1.73 m².
- Urine output: <0.3 mL/kg/h for ≥24 hours or anuria for ≥12 hours. 9, 8
Staging Principles
- Staging is applied over the entire clinical course of AKI, independent of the timing used for initial diagnosis (48 h for absolute creatinine rise vs. 7 days for relative rise). 9, 8
Clinical Implications
- Even the modest 0.3 mg/dL creatinine rise that defines Stage 1 is linked to an ≈4‑fold increase in in‑hospital mortality. 9
- Stage 1 encompasses a heterogeneous patient group because meeting either the absolute or relative creatinine criterion is sufficient; the absolute increase may represent a smaller physiological change than a 50 % relative rise, affecting prognosis. 9, 8
Post‑AKI Follow‑Up
- Patients should be re‑evaluated at 3 months after an AKI episode to determine resolution, new‑onset chronic kidney disease, or progression of pre‑existing CKD. 9, 8
- Those without established CKD but who have experienced AKI are considered at increased risk and should be managed according to KDOQI guidelines for at‑risk populations. 9, 8